The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly

Clinical Endocrinology

Volumn 71, Issue 6, 2009, Pages 840-845

  Karavitaki, N ^a   Fernandez, A ^a   Fazal Sanderson, V ^a   Wass, J A H ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DIET RESTRICTION; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DAY CURVE; GROWTH HORMONE SECRETING ADENOMA; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MALE; ORAL GLUCOSE TOLERANCE TEST; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACROMEGALY; ADOLESCENT; ADULT; AGED; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; YOUNG ADULT;

EID: 70449441124     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03578.x     Document Type: Article

References (16)

1. Giustina, A., Barkan, A., Casanueva, F.F. et al. (2000) Consensus: criteria for cure of acromagely: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526 529.
2. Consensus Statement (2004) Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. Journal of Clinical Endocrinology and Metabolism, 89, 3099 3102.
3. Arafat, A.M., Mohlig, M., Weickert, M.O. et al. (2008) Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. Journal of Clinical Endocrinology and Metabolism, 93, 1254 1262.
4. Bates, A.S., Van't Hoff, W., Jones, J.M. et al. (1993) An audit of outcome of treatment in acromegaly. The Quarterly Journal of Medicine, 86, 293 299.
5. Orme, S.M., McNally, J.Q., Cartwright, R.A. et al. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. Journal of Clinical Endocrinology and Metabolism, 83, 2730 2734.
6. Hartman, M.L., Pincus, S.M., Johnson, M.L. et al. (1994) Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. The Journal of Clinical Investigation, 94, 1277 1288.
7. Ho, K.K.Y. Weissberger, A.J. (1994) Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clinical Endocrinology, 41, 75 83.
8. Dimaraki, E.V., Jaffe, C.A., DeMott-Friberg, R. et al. (2002) Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. Journal of Clinical Endocrinology and Metabolism, 87, 3537 3542.
9. Jayasena, C.N., Wujanto, C., Donaldson, M. et al. (2008) Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patients. Clinical Endocrinology, 68, 36 41.
10. Jenkins, D., O'Brien, I., Johnson, A. et al. (1995) The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly. Clinical Endocrinology, 43, 517 522.
11. Minuto, F., Resmini, E., Boschetti, M. et al. (2004) Assessment of disease activity in acromegaly by means of a single blood sample; comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Clinical Endocrinology, 61, 138 144.
12. Parfitt, V.J., Flanagan, D., Wood, P. et al. (1998) Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1. Clinical Endocrinology, 49, 647 652.
13. Semer, M., Faria, A.C., Nery, M. et al. (1995) Growth hormone pulsatility in active and cured acromegalic patients. Journal of Clinical Endocrinology and Metabolism, 80, 3767 3770.
14. Bajuk Studen, K. Barkan, A. (2008) Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of different sampling models. Journal of Clinical Endocrinology and Metabolism, 93, 491 496.
15. Kaltsas, G.A., Isidori, A.M., Florakis, D. et al. (2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. Journal of Clinical Endocrinology and Metabolism, 86, 1645 1652.
16. Colao, A., Pivonello, R., Cavallo, L.M. et al. (2006) Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. Clinical Endocrinology, 65, 250 256.